Chia Tai Enterprises International Limited (HKG:3839)
1.860
-0.040 (-2.11%)
May 29, 2025, 4:08 PM HKT
HKG:3839 Revenue
Chia Tai Enterprises International had revenue of $165.04M USD in the quarter ending March 31, 2025, with 201.97% growth. This brings the company's revenue in the last twelve months to $418.14M, up 125.86% year-over-year. In the year 2024, Chia Tai Enterprises International had annual revenue of $307.75M with 76.89% growth.
Revenue (ttm)
$418.14M
Revenue Growth
+125.86%
P/S Ratio
0.14
Revenue / Employee
$464.59K
Employees
900
Market Cap
457.36M HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 307.75M | 133.77M | 76.89% |
Dec 31, 2023 | 173.98M | 14.74M | 9.26% |
Dec 31, 2022 | 159.24M | 16.83M | 11.82% |
Dec 31, 2021 | 142.41M | 48.83M | 52.18% |
Dec 31, 2020 | 93.58M | -11.47M | -10.91% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
WuXi Biologics | 19.87B |
CSPC Pharmaceutical Group | 30.87B |
Akeso | 2.26B |
Sino Biopharmaceutical | 30.72B |